Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Financings

SureNano Announces Private Placement

SURE · Price

Executive Summary

  • SureNano Science Ltd. announced a private placement to raise up to $1,250,000 by selling up to 10,000,000 units at $0.125 per unit.
  • Each unit consists of one common share and one warrant allowing purchase of an additional share at $0.35 for 24 months, with acceleration provisions tied to the CSE price.
  • Proceeds will be used for operating expenses, legal and audit fees, general working capital, market expansion for the SureNano™ surfactant, and exploration of complementary industries.

Key Details

  • Units Offered: Up to 10,000,000 units @ $0.125 each → maximum gross proceeds $1,250,000.
  • Unit Composition: 1 common share + 1 warrant (right to purchase one additional common share at $0.35).
  • Warrant Terms: exercisable for 24 months; acceleration if CSE price ≥ $0.50 for ten consecutive trading days after four months and one day post‑closing, causing expiry 30 days after notice.
  • Finder Compensation: 6% cash commission + 6% of the warrants (exercisable at $0.35) for parties introducing subscribers.
  • Hold Period: All securities subject to a four‑month‑and‑one‑day hold period.
  • Use of Proceeds: Operating expenses, legal and audit fees, general working capital, exploration of new markets for SureNano™ surfactor, and investigation of complementary industries.

Notable Quotes

  • “We intend to use the proceeds for operating expenses, including legal and audit fees, and general working capital, including to explore new markets for our SureNano™ surfactant, and to investigate complementary industries.” – Charles MaLette, CEO, President, Director & Secretary.
Read the original news release →

More from SureNano Science Ltd. - New Listing